BackRallybio Overview

Rallybio Current Cash

Rallybio's current cash is $93M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$92.85M
↑ 883.05% YoYΔ $83.40M vs prior year quarter

Peer trimmed avg / median

Loading

Rallybio Current Cash History

Loading

Rallybio vs. peers: Current Cash Comparison

Loading

Rallybio Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Rallybio (RLYB) FAQ

Rallybio (RLYB) currently reports a current cash of $93M as of June 2026. That compares with $9.4M in the prior-year period — up 883.0% year over year. Use the charts on this page to explore Rallybio's current cash history and peer comparisons.

Rallybio's current cash increased from $9.4M to $93M — a 883.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rallybio reported $93M in current cash as of June 2026. That compares with $9.4M in the prior-year period — up 883.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $93M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rallybio, and consider following RLYB for alerts when major investors trade the stock.

Rallybio is classified in the Healthcare sector. On current cash, it currently shows $93M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RLYB with unrelated industries.